January 17th 2025
Mineralys Therapeutics also expects topline data from its phase 2 study of lorundrostat for the treatment of uncontrolled hypertension or resistant hypertension when used as an add-on therapy.
What Regimen to Minimize Thromboembolic Risk and Bleeding?
May 9th 2014Aging baby boomers will more frequently appear in primary care offices with cardiovascular diseases that place them at high risk for both clotting and bleeding. Many will also have atrial fibrillation. Is there a sure-fire therapeutic formula for all?
Statins May Improve Erectile Dysfunction: A New Way to Encourage Compliance?
April 28th 2014The exact mechanism responsible for this effect is still open for debate. A salutatory side effect of the news may be the impact on medication adherence among men with both elevated LDL-C and erectile dysfunction.
A Wide, Slow Cardiac Rhythm in a Lethargic Patient
April 25th 2014This 32-year-old woman's family brought her to the ED after 2 days of progressive confusion, fatigue, and weakness. Her multiple medical problems included juvenile-onset diabetes mellitus. Here, more details and a management challenge.